Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Alvesco HFA

Client Email

Product

Alvesco HFA
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Alvesco HFA

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 4 CEP/COS, 1 JDMF, 3 EU WC, 4 KDMF, 3 NDC API, 2 VMF, 9 Listed Suppliers, $ API Reference Price

12 API Suppliers
6 USDMF
4 CEP/COS
1 JDMF
3 EU WC
4 KDMF
3 NDC API
2 VMF
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 5 FDA Orange Book, 16 Europe, 4 Canada, 2 Australia, 8 South Africa, 5 Listed Dossiers

40 FDF Dossiers
5 FDA Orange Book
16 Europe
4 Canada
2 Australia
8 South Africa
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;NASAL - 0.037MG/INH, AEROSOL, METERED;INHALATION - 0.08MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY

AEROSOL, METERED;NASAL - 0.037MG/INH
AEROSOL, METERED;INHALATION - 0.08MG/INH
AEROSOL, METERED;INHALATION - 0.16MG/INH
SPRAY, METERED;NASAL - 0.05MG/SPRAY

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 1 DKSH, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 2 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 15 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 7 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 3 The Dow Chemical Company, 1 Vasa Pharmachem

1 Rochem International Inc
1 SPI Pharma
1 DKSH
6 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 ACG Worldwide
1 Actylis
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
10 Corel Pharma Chem
2 DFE Pharma
5 Gangwal Chemicals
5 Ideal Cures Pvt Ltd
15 Kerry
4 Kima Chemical
6 Lonza Capsugel
6 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
1 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
7 Roquette
6 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
8 Sigachi Industries
3 The Dow Chemical Company
1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 20 Controlled & Modified Release, 19 Fillers, Diluents & Binders, 15 Thickeners and Stabilizers, 14 Direct Compression, 8 Co-Processed Excipients, 7 Disintegrants & Superdisintegrants, 7 Granulation, 6 Film Formers & Plasticizers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Solubilizers, 4 Vegetarian Capsules, 4 Taste Masking, 3 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 2 Coloring Agents, 2 Lubricants & Glidants, 2 Parenteral, 1 Emulsifying Agents

41 Coating Systems & Additives
20 Controlled & Modified Release
19 Fillers, Diluents & Binders
15 Thickeners and Stabilizers
14 Direct Compression
8 Co-Processed Excipients
7 Disintegrants & Superdisintegrants
7 Granulation
6 Film Formers & Plasticizers
5 Rheology Modifiers
5 Empty Capsules
4 Solubilizers
4 Vegetarian Capsules
4 Taste Masking
3 Chewable & Orodispersible Aids
3 API Stability Enhancers
2 Coloring Agents
2 Lubricants & Glidants
2 Parenteral
1 Emulsifying Agents

DIGITAL CONTENT

7 NEWS #PharmaBuzz

7 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 13 Finished Drug Prices, 3 Annual Reports

3 US Medicaid Prescriptions
13 Finished Drug Prices
3 Annual Reports

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

4 US Patents, 15 Health Canada Patents

4 US Patents
15 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ API Ref.Price (USD/KG) : 25,764 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4COVIS

filter Patent Number Reset all filters

4 All

01 48371292

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Blank

filter Expiration Date Reset all filters

4 All

01 42028-02-01

Coral Ciclesonide

US Patents
Health Canada Patents

Product Main Page

01

COVIS

Formnext Forum

Not Confirmed

COVIS

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-01

CICLESONIDE

US Patent Number : 8371292

Drug Substance Claim :

Drug Product Claim :

Application Number : 22004

Patent Use Code : U-1356

Delist Requested :

Patent Use Description : TREATMENT OF NASAL SYM...

Patent Expiration Date : 2028-02-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

COVIS

Formnext Forum

Not Confirmed

COVIS

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-01

CICLESONIDE

US Patent Number : 8371292

Drug Substance Claim :

Drug Product Claim :

Application Number : 21658

Patent Use Code : U-1355

Delist Requested :

Patent Use Description : MAINTENANCE TREATMENT ...

Patent Expiration Date : 2028-02-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

COVIS

Formnext Forum

Not Confirmed

COVIS

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-01

CICLESONIDE

US Patent Number : 8371292

Drug Substance Claim :

Drug Product Claim :

Application Number : 202129

Patent Use Code : U-1357

Delist Requested :

Patent Use Description : TREATMENT OF SYMPTOMS ...

Patent Expiration Date : 2028-02-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

COVIS

Formnext Forum

Not Confirmed

COVIS

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-01

CICLESONIDE

US Patent Number : 8371292

Drug Substance Claim :

Drug Product Claim :

Application Number : 21658

Patent Use Code : U-1355

Delist Requested :

Patent Use Description : MAINTENANCE TREATMENT ...

Patent Expiration Date : 2028-02-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?